Cancer information

Diagnosis and treatment of early-stage lung cancer｜Cancer Lecture series (2025/06/06｜Invited by HKHCA)

Media coverage: XingTao Headline Daily–Medical Fun Enjoy


background

  • Event date：2025-06-06
  • Inviting organization: Hong Kong Health Care Alliance (Hong Kong Health Care Alliance, HKHCA)
  • speaker: Dr. Li Yu Chung, Jacky (Hong Kong United Cancer Centre HKUOC｜Clinical Oncology Specialist)
  • Video link：Watch the lecture video
  • Disclaimer of Warranty: This article is for health education purposes only and is not individual medical or insurance advice. Any treatment plan must be formulated by the doctor after evaluation based on the specific situation of the patient.

Summary of Key points

The diagnosis and treatment of early-stage lung cancer is a crucial topic in current cancer research. The following are the key points from the lecture, intended to provide health education information:

  • Early Lung Cancer Screening: Low-dose computed tomography (LDCT) is considered an effective tool for detecting early-stage lung cancer, especially in high-risk groups such as long-term smokers. Studies have shown that LDCT can significantly improve early diagnosis rates (Reference: National Lung Screening Trial, 2011).
  • Diagnostic Process: Diagnosing lung cancer typically involves imaging tests, tissue biopsy, and genetic testing (such as EGFR gene mutation and ALK gene testing) to determine the cancer stage and molecular characteristics. Learn more about the lung cancer diagnostic process.
  • Treatment Options: Early-stage lung cancer is primarily treated with surgical resection. For patients who are not candidates for surgery, stereotactic body radiotherapy (SBRT) is an alternative. In addition, neoadjuvant therapy (such as chemotherapy and radiotherapy) can improve treatment outcomes in specific circumstances (Reference: ESMO Guidelines, 2023).
  • Personalized Treatment Trend: Hong Kong United Oncology Centre (HKUOC) focuses on providing patients with personalized treatment plans, selecting appropriate chemotherapy, targeted therapy, or immunotherapy based on individual circumstances, aiming to optimize treatment outcomes.

Inspiration for patients

Understanding early lung cancer screening and diagnostic methods can help increase the chances of early detection. For more information on local lung cancer screening, please refer to the Hong Kong Department of Health's Cancer Prevention and Screening Recommendations.

 

Frequently Asked Questions

Q: What are the early symptoms of lung cancer?
A: Early symptoms of lung cancer may not be obvious, but common symptoms include persistent cough, chest pain, shortness of breath, and weight loss. If you have any concerns, a chest X-ray or LDCT screening is recommended (Reference:American Cancer Society, 2023).
Q: What is the purpose of EGFR gene mutation testing?
A: EGFR gene mutation testing helps determine suitability for targeted drug therapy, especially for patients with lung adenocarcinoma. This test is an important part of precision medicine (Reference:NCCN Guidelines, 2023).
Q: Is immunotherapy suitable for all lung cancer patients?
A: Immunotherapy treatment is not suitable for all patients and requires evaluation by a doctor based on tumor characteristics and the patient's health condition. Treatment plans should be individualized.

 

Speaker introduction

Dr. Li Yu Chung, Jacky

  • Specialist in Clinical Oncology (Hong Kong United Cancer Centre HKUOC)
  • Qualifications: MBBS (HK)｜FRCR (UK)｜FHKCR｜FHKAM (Radiology)

References

  • National Lung Screening Trial Research Team. (2011). Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine.
  • ESMO Clinical Practice Guidelines. (2023). Non-Small Cell Lung Cancer.
  • National Comprehensive Cancer Network (NCCN). (2023). Lung Cancer Guidelines.
  • American Cancer Society. (2023). Lung Cancer Early Detection and Diagnosis.

Personalized treatment policy of the United Cancer Centre of Hong Kong

Hong Kong United Oncology Centre (HKUOC) is patient-centered and focuses on lung cancer treatment, cancer screening, and diagnostic services. The center tailors treatment plans for each patient, encompassing chemotherapy, targeted therapy, immunotherapy, and radiotherapy, and ensures comprehensive support for patients throughout their treatment through close communication with their attending physicians.

For more information

For more information about lung cancer screening, early lung cancer symptoms, or treatment options, please contact Hong Kong United Oncology Centre (HKUOC):

WhatsApp Facebook WeChat Weibo